Thrivent Financial for Lutherans’s Select Medical SEM Stock Holding History

Thrivent Financial for Lutherans’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-73,753	Closed	-$1.2M	–	2676
2026 Q1	$1.2M	Sell	73,753 -2,166	-3%	-$33.9K	﹤0.01%	1784
2025 Q4	$1.13M	Sell	75,919 -3,890	-5%	-$55K	﹤0.01%	1851
2025 Q3	$1.02M	Buy	79,809 +3,051	+4%	+$40.7K	﹤0.01%	1769
2025 Q2	$1.17M	Sell	76,758 -187	-0.2%	-$2.92K	﹤0.01%	1691
2025 Q1	$1.28M	Sell	76,945 -4,015	-5%	-$73.9K	﹤0.01%	1554
2024 Q4	$1.53M	Sell	80,960 -72,908	-47%	-$1.41M	﹤0.01%	1634
2024 Q3	$2.89M	Sell	153,868 -10,785	-7%	-$207K	0.01%	1208
2024 Q2	$3.11M	Sell	164,653 -4,997	-3%	-$85.2K	0.01%	1111
2024 Q1	$2.76M	Sell	169,650 -4,597	-3%	-$67.3K	0.01%	1184
2023 Q4	$2.21M	Sell	174,247 -3,136	-2%	-$39.6K	﹤0.01%	1314
2023 Q3	$2.42M	Sell	177,383 -8,072	-4%	-$125K	0.01%	1169
2023 Q2	$3.18M	Sell	185,455 -6,437	-3%	-$99.7K	0.01%	1055
2023 Q1	$2.67M	Sell	191,892 -6,713	-3%	-$98.8K	0.01%	1106
2022 Q4	$2.66M	Buy	198,605 +141	+0.1%	+$1.82K	0.01%	1082
2022 Q3	$2.36M	Buy	198,464 +9,967	+5%	+$142K	0.01%	1118
2022 Q2	$2.4M	Buy	188,497 +28,051	+17%	+$360K	0.01%	1127
2022 Q1	$2.07M	Buy	160,446 +134	+0.1%	+$1.77K	﹤0.01%	1299
2021 Q4	$2.54M	Buy	160,312 +612	+0.4%	+$10.4K	﹤0.01%	1231
2021 Q3	$3.11M	Sell	159,700 -4,133	-3%	-$82K	0.01%	1089
2021 Q2	$3.73M	Sell	163,833 -766	-0.5%	-$15.9K	0.01%	1058
2021 Q1	$3.02M	Sell	164,599 -1,099	-0.7%	-$18K	0.01%	1149
2020 Q4	$2.47M	Buy	165,698 +659	+0.4%	+$8.6K	0.01%	1186
2020 Q3	$1.85M	Sell	165,039 -1,968	-1%	-$19.4K	﹤0.01%	1201
2020 Q2	$1.32M	Sell	167,007 -148	-0.1%	-$1.23K	﹤0.01%	1311
2020 Q1	$1.35M	Buy	167,155 +8,345	+5%	+$99.2K	﹤0.01%	1139
2019 Q4	$2M	Sell	158,810 -1,188	-0.7%	-$12.8K	0.01%	1043
2019 Q3	$1.43M	Buy	159,998 +2,437	+2%	+$21.3K	﹤0.01%	1176
2019 Q2	$1.35M	Buy	157,561 +4,022	+3%	+$31.8K	﹤0.01%	1215
2019 Q1	$1.17M	Buy	153,539 +11,464	+8%	+$92.2K	﹤0.01%	1271
2018 Q4	$1.18M	Buy	142,075 +3,124	+2%	+$29.9K	﹤0.01%	1067
2018 Q3	$1.38M	Buy	138,951 +2,400	+2%	+$24.8K	﹤0.01%	1088
2018 Q2	$1.33M	Buy	136,551 +3,079	+2%	+$30.2K	﹤0.01%	1079
2018 Q1	$1.24M	Buy	133,472 +10,935	+9%	+$104K	﹤0.01%	1106
2017 Q4	$1.17M	Buy	122,537 +2,417	+2%	+$23.1K	﹤0.01%	1157
2017 Q3	$1.24M	Sell	120,120 -501	-0.4%	-$4.63K	﹤0.01%	1058
2017 Q2	$998K	Buy	120,621 +7,405	+7%	+$55.6K	﹤0.01%	1118
2017 Q1	$814K	Buy	113,216 +5,587	+5%	+$40.5K	﹤0.01%	1283
2016 Q4	$768K	Buy	107,629 +6,310	+6%	+$43.9K	﹤0.01%	1289
2016 Q3	$737K	Buy	101,319 +7,183	+8%	+$45.7K	﹤0.01%	1269
2016 Q2	$551K	Buy	94,136 +4,677	+5%	+$31K	﹤0.01%	1377
2016 Q1	$569K	Buy	89,459 +5,772	+7%	+$31K	﹤0.01%	1316
2015 Q4	$537K	Buy	83,687 +2,858	+4%	+$17.9K	﹤0.01%	1316
2015 Q3	$470K	Buy	80,829 +10,487	+15%	+$77.8K	﹤0.01%	1241
2015 Q2	$614K	Buy	70,342 +3,712	+6%	+$31.2K	﹤0.01%	1008
2015 Q1	$532K	Buy	+66,630	New	+$498K	﹤0.01%	1084
2014 Q3	–	Sell	-145,232	Closed	-$1.22M	–	1881
2014 Q2	$1.22M	Buy	+145,232	New	+$1.13M	0.01%	825

Other funds holding SEM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

DAM

Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

Thrivent Financial for Lutherans's SEM Position: Q2 2026 in Review

Thrivent Financial for Lutherans sold out of Select Medical (SEM) in Q2 2026, closing a stake of 73,753 shares — an estimated $1.2M sold.

Thrivent Financial for Lutherans first reported a position in SEM in Q2 2014 and held it in 46 quarters. The position peaked at $3.73M in Q2 2021. 238 funds tracked by Wall St. Rank hold SEM as of Q2 2026.

Thrivent Financial for Lutherans reported no remaining Select Medical position as of Q2 2026 after selling out during the quarter.
Thrivent Financial for Lutherans sold 73,753 Select Medical shares in Q2 2026, an estimated $1.2M.
Thrivent Financial for Lutherans first reported a position in Select Medical in Q2 2014 and held it in 46 quarters.
Thrivent Financial for Lutherans's Select Medical position peaked at $3.73M in Q2 2021.
238 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.

Based on Thrivent Financial for Lutherans's 13F filing for Q2 2026, filed 14 Aug 2026.